SURG
#4795
SurgePays, Inc. - Common Stock
0.1 8 USD
+0.06%
Market Price
Sector: Technology
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+5.88%
Monthly Change
-25.00%
6 month change
-79.55%
Year Change
-93.18%
Previous Close
0.1 7
Open
0.1 8
Low
0.1 8
High
0.1 8
Volume
14
Financials
- Market Capitalization 9.52 M
- Employee 20
- Founded 2006
- CEO N/A
- Website www.surgepays.com
- Headquarter Nevada, United States
- FIGI BBG000RCQLW3
- Industry Software—Application
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.93
Price to sales ratio
0.59
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4774 |  NVNI Nvni Group Limited - Ordinary Shares | 1.04 USD | +1.96% | -2.80% | -5.45% | +60.00% | 10.43 M USD | ||
| 4783 |  NXTT Next Technology Holding Inc. - Ordinary Shares | 6.91 USD | +1.77% | -13.62% | +1014.52% | +118.67% | 10.18 M USD | ||
| 4803 |  PDC Perpetuals.com Ltd - American Depositary Shares | 3.03 USD | -6.19% | -4.42% | -20.05% | -61.93% | 9.14 M USD | ||
| 4817 |  VS Versus Systems Inc. - Common Stock | 1.37 USD | +4.58% | +3.01% | -1.44% | +51.25% | 8.51 M USD |
Frequently asked questions about SurgePays, Inc. Common Stock
What is the SurgePays, Inc. Common Stock stock price today?
The current price of SurgePays, Inc. Common Stock (SURG) is 0.18. Over the past 24 hours, the stock has changed by +5.88%. Follow the SURG chart for real-time price dynamics.
What is the stock ticker of SurgePays, Inc. Common Stock?
SurgePays, Inc. Common Stock trades under the ticker SURG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SurgePays, Inc. Common Stock stock going up?
SURG has changed by +5.88% over the last week, -25.00% over the last month, and -93.18% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of SurgePays, Inc. Common Stock?
SurgePays, Inc. Common Stock currently has a market capitalization of 9.52 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were SurgePays, Inc. Common Stock earnings last quarter?
Last quarter, SurgePays, Inc. Common Stock reported earnings of 0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was SurgePays, Inc. Common Stock revenue for the last quarter?
SurgePays, Inc. Common Stock reported quarterly revenue of 16.2 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was SurgePays, Inc. Common Stock net income for the last quarter?
SurgePays, Inc. Common Stock reported net income of 1.29 M for the last quarter. The previous quarter showed -12.05 M, which means net income changed by +110.69%.
How many employees does SurgePays, Inc. Common Stock have?
As of the latest available data, SurgePays, Inc. Common Stock has 20 employees. Workforce size can provide additional context about the company's scale and operations.
What is SurgePays, Inc. Common Stock EBITDA?
SurgePays, Inc. Common Stock EBITDA is -5.03 M, and its EBITDA margin is -31.05%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy SurgePays, Inc. Common Stock stock?
You can buy SurgePays, Inc. Common Stock (SURG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SurgePays, Inc. Common Stock stock?
Investing in SurgePays, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SURG chart and related analysis on metatrader.com as part of your research.